» Articles » PMID: 31726650

Prognostic Factors in a Large Nationwide Cohort of Histologically Confirmed Primary and Secondary Angiosarcomas

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2019 Nov 16
PMID 31726650
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Angiosarcoma (AS) is a rare sarcoma of endothelial origin, arising spontaneously (primary AS) or after external damage such as radiation therapy or UV exposure (secondary AS). To date, reliable assessment of prognostic factors has proven difficult, due to disease rarity and heterogeneity of study cohorts. Although large registries provide relatively large AS patient series, these cases often lack histological confirmation. This study aimed to analyze AS prognostic factors in a large nationwide cohort of histologically confirmed cases, established through linkage of clinical data from the Netherlands Cancer Registry and pathology data from the Dutch pathology registry (PALGA). All cases were reviewed by an expert pathologist, showing a 16% discordance rate. Multivariable Cox regression survival analysis among 479 confirmed AS patients revealed remarkably poorer overall survival (OS) for primary AS compared to secondary AS (7 vs 21 months, Hazard ratio (HR) = 1.5; 95% confidence interval (CI) = 1.2-1.9). Age above 65 years, male gender, and no surgical treatment also significantly correlated to worse OS. Overall, OS was relatively poor, with a median of 13 months (95% CI = 10-16 months) and 22% five-year survival rate. With this study, we illustrate AS heterogeneity in clinical behavior and show for the first time better survival for secondary AS compared to primary AS.

Citing Articles

Angiosarcoma: clinical outcomes and prognostic factors, a single-center analysis.

Roohani S, Rotermund T, Ehret F, Dziodzio T, Jarosch A, Schafer F J Cancer Res Clin Oncol. 2024; 150(6):326.

PMID: 38914779 PMC: 11196347. DOI: 10.1007/s00432-024-05835-x.


A Population-Based Long-Term Follow-Up of Soft Tissue Angiosarcomas: Characteristics, Treatment Outcomes, and Prognostic Factors.

Holm C, Orholt M, Talman M, Abebe K, Thorn A, Baad-Hansen T Cancers (Basel). 2024; 16(10).

PMID: 38791913 PMC: 11120488. DOI: 10.3390/cancers16101834.


Intraoral angiosarcoma with unusual clinical presentation: A case report.

AlAli M, AlOtaibi L, AlMohaya M, Khoja H Heliyon. 2023; 9(6):e17056.

PMID: 37389059 PMC: 10300316. DOI: 10.1016/j.heliyon.2023.e17056.


Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).

Versleijen-Jonkers Y, Hillebrandt-Roeffen M, Weidema M, Mooren J, von Rhein D, de Bitter T Sci Rep. 2023; 13(1):2653.

PMID: 36788310 PMC: 9929321. DOI: 10.1038/s41598-023-29569-x.


Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.

van Ravensteijn S, Versleijen-Jonkers Y, Hillebrandt-Roeffen M, Weidema M, Nederkoorn M, Bol K Cancers (Basel). 2022; 14(23).

PMID: 36497420 PMC: 9739001. DOI: 10.3390/cancers14235938.


References
1.
Perrier L, Rascle P, Morelle M, Toulmonde M, Ranchere Vince D, Cesne A . The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group. PLoS One. 2018; 13(4):e0193330. PMC: 5886412. DOI: 10.1371/journal.pone.0193330. View

2.
Antonescu C . Malignant vascular tumors--an update. Mod Pathol. 2014; 27 Suppl 1:S30-8. DOI: 10.1038/modpathol.2013.176. View

3.
Buehler D, Rice S, Moody J, Rush P, Hafez G, Attia S . Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience. Am J Clin Oncol. 2013; 37(5):473-9. PMC: 3664266. DOI: 10.1097/COC.0b013e31827e4e7b. View

4.
Shon W, Jenkins S, Ross D, Seitz R, Beck R, Ring B . Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness. J Cutan Pathol. 2011; 38(12):961-6. DOI: 10.1111/j.1600-0560.2011.01790.x. View

5.
Sinnamon A, Neuwirth M, McMillan M, Ecker B, Bartlett E, Zhang P . A prognostic model for resectable soft tissue and cutaneous angiosarcoma. J Surg Oncol. 2016; 114(5):557-563. DOI: 10.1002/jso.24352. View